Caffeine Citrate

枸橼酸咖啡因

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameCaffeine Citrate
Drug Alias Name枸椽酸咖啡因Coffeinum Citricum柠檬酸咖啡因CafneaCafcit +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2 receptor antagonists
TargetsAdenosine A2 receptorAdenosine A1 receptor
Therapy Area/IndicationsHypoxiaPain, PostoperativeInfant, Premature, Diseases +[17] 
Global Approved IndicationsApnea
Approved Indications in ChinaApnea
Original Approved Country/TerritoryUnited States
Original Approved Date1999/09/21
Country/TerritoryCanadaZambiaUnited States +[21] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHikma Pharmaceuticals PlcBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Nutrition Of Central America And Panama (Incap)Children'S National Research InstituteKinshasa School Of Public Health +[17] 
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentUniversity Of Tunis +[12] 
Active IndicationsHypoxiaInfant, Premature, DiseasesPremature Birth +[10] 
Inactive IndicationsPain, PostoperativeObstetric Labor, PrematureNarcolepsy +[7] 

Other Information

ATC CodeN06BC01
Related LinksWikipediaKEGG